Reuters logo
BRIEF-Heat Biologics says co terminated its at market issuance sales agreement with FBR capital markets & co
November 7, 2017 / 12:28 PM / a month ago

BRIEF-Heat Biologics says co terminated its at market issuance sales agreement with FBR capital markets & co

Nov 7 (Reuters) - Heat Biologics Inc

* Heat Biologics Inc - ‍on Nov. 3, 2017, co terminated its at market issuance sales agreement with FBR capital markets & co, dated Aug. 15, 2016​

* Heat Biologics Inc - ‍no additional sales of company's common stock will be made pursuant to agreement - SEC filing​ Source text: [bit.ly/2Agzf0E] Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below